FIELD: biotechnology.
SUBSTANCE: antibody to a respiratory syncytial virus (hereinafter – RSV) or its antigen-binding fragment are proposed. The use of the specified antibody for protection from RSV infection in a subject who needs it is also proposed. The invention also relates to nucleic acid encoding the specified antibody, an expression vector, an isolated cell, and a method for the production of an antibody or an antigen-binding fragment.
EFFECT: invention allows for effective neutralization of RSV strains subtypes A and B.
25 cl, 12 dwg, 14 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MOLECULE SPECIFICALLY BINDING TO RSV | 2009 |
|
RU2540020C2 |
| BISPECIFIC MOLECULES, IMMUNOREACTIVE WITH IMMUNE EFFECTOR CELLS EXPRESSING AN ACTIVATING RECEPTOR | 2014 |
|
RU2721707C2 |
| PROTEINS BASED ON ANTIBODY WITH GRAFTED CYTOKINE AND METHODS FOR THEIR USE IN IMMUNE DISORDERS | 2018 |
|
RU2786730C2 |
| ANTIBODIES WHICH BIND TO SORTILIN AND INHIBIT THE BINDING OF PROGRANULIN | 2016 |
|
RU2735639C2 |
| ANTIBODY TO CD40, ITS ANTIGENE-BINDING FRAGMENT AND ITS MEDICAL USE | 2018 |
|
RU2779128C2 |
| ANTIBODY-BASED PROTEINS WITH CYTOKINE GRAFTS AND METHODS OF THEIR USE IN CANCER TREATMENT | 2018 |
|
RU2815389C2 |
| ANTIBODIES AGAINST XI CLOTTING FACTOR | 2017 |
|
RU2757314C2 |
| ANTIBODIES TO PROTEIN CD38, AND THEIR USE | 2019 |
|
RU2776795C2 |
| ANTIGENIC POLYPEPTIDES BASED ON THE RESPIRATORY SYNCYTIAL VIRUS SEQUENCE | 2019 |
|
RU2807992C2 |
| ANTIBODIES BINDING TO GPRC5D | 2019 |
|
RU2797268C2 |
